Hans Rollema

9.8k total citations · 1 hit paper
110 papers, 5.4k citations indexed

About

Hans Rollema is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Hans Rollema has authored 110 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 55 papers in Cellular and Molecular Neuroscience and 17 papers in Neurology. Recurrent topics in Hans Rollema's work include Receptor Mechanisms and Signaling (43 papers), Neurotransmitter Receptor Influence on Behavior (34 papers) and Neuroscience and Neuropharmacology Research (28 papers). Hans Rollema is often cited by papers focused on Receptor Mechanisms and Signaling (43 papers), Neurotransmitter Receptor Influence on Behavior (34 papers) and Neuroscience and Neuropharmacology Research (28 papers). Hans Rollema collaborates with scholars based in United States, Netherlands and Sweden. Hans Rollema's co-authors include Raymond S Hurst, Ben H.C. Westerink, Jan B. De Vries, Daniel Bertrand, G. Damsma, Anne W. Schmidt, Yi Lu, David W. Schulz, Kathryn Williams and A. S. Horn and has published in prestigious journals such as Nature, Diabetes and Biological Psychiatry.

In The Last Decade

Hans Rollema

109 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nicotinic acetylcholine receptors: From basic science to therapeutics

2012 411 citations Raymond S Hurst, Hans Rollema et al. Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hans Rollema United States	35	3.0k	2.6k	1.1k	735	604	110	5.4k
Gavin J. Kilpatrick United Kingdom	42	2.7k 0.9×	3.1k 1.2×	905 0.8×	439 0.6×	372 0.6×	83	6.4k
Josée E. Leysen Belgium	45	3.4k 1.1×	3.7k 1.4×	656 0.6×	625 0.9×	500 0.8×	127	6.4k
J.E. Leysen Belgium	38	2.8k 0.9×	3.6k 1.3×	671 0.6×	1.3k 1.8×	635 1.1×	97	6.1k
M. Da Prada Switzerland	42	2.2k 0.7×	2.3k 0.9×	929 0.8×	568 0.8×	737 1.2×	142	6.7k
P. C. Waldmeier Switzerland	40	2.3k 0.8×	2.8k 1.0×	556 0.5×	608 0.8×	562 0.9×	155	5.2k
Hans Rommelspacher Germany	43	2.3k 0.8×	2.5k 0.9×	553 0.5×	376 0.5×	744 1.2×	178	5.4k
Aaron Janowsky United States	43	2.6k 0.9×	3.5k 1.3×	477 0.4×	438 0.6×	649 1.1×	129	5.5k
Robert J. Naylor United Kingdom	39	2.0k 0.7×	2.9k 1.1×	571 0.5×	466 0.6×	518 0.9×	134	4.9k
Pierre M. Laduron Belgium	43	4.9k 1.6×	5.5k 2.1×	1.1k 1.0×	551 0.7×	554 0.9×	177	8.3k
R.J. Naylor United Kingdom	51	2.8k 1.0×	4.7k 1.8×	1.0k 0.9×	742 1.0×	924 1.5×	174	8.1k

Countries citing papers authored by Hans Rollema

Since Specialization

Citations

This map shows the geographic impact of Hans Rollema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Rollema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Rollema more than expected).

Fields of papers citing papers by Hans Rollema

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Rollema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Rollema. The network helps show where Hans Rollema may publish in the future.

Co-authorship network of co-authors of Hans Rollema

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Rollema. A scholar is included among the top collaborators of Hans Rollema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Rollema. Hans Rollema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nau, Jeffrey, D.J. Wyatt, Hans Rollema, & Christopher Crean. (2021). A Phase I, Open-label, Randomized, 2-Way Crossover Study to Evaluate the Relative Bioavailability of Intranasal and Oral Varenicline. Clinical Therapeutics. 43(9). 1595–1607. 14 indexed citations

Hurst, Raymond S, Hans Rollema, & Daniel Bertrand. (2012). Nicotinic acetylcholine receptors: From basic science to therapeutics. Pharmacology & Therapeutics. 137(1). 22–54. 411 indexed citations breakdown →

Rollema, Hans, Alka Shrikhande, J.W. Coe, et al.. (2010). Pre‐clinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence. British Journal of Pharmacology. 160(2). 334–345. 131 indexed citations

Repérant, Christelle, Stéphanie Pons, Éric Dufour, et al.. (2009). Effect of the α4β2∗ nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in β2 knock-out mice with selective re-expression of the β2 subunit in the ventral tegmental area. Neuropharmacology. 58(2). 346–350. 34 indexed citations

Johnson, David E., Frank M. Nedza, Douglas K. Spracklin, et al.. (2004). The role of muscarinic receptor antagonism in antipsychotic-induced hippocampal acetylcholine release. European Journal of Pharmacology. 506(3). 209–219. 32 indexed citations

Sprouse, Jeffrey, et al.. (2001). Activation of postsynaptic 5‐HT_1A receptors by fluoxetine despite the loss of firing‐dependent serotonergic input: Electrophysiological and neurochemical studies. Synapse. 41(1). 49–57. 23 indexed citations

Johnson, David E., Hans Rollema, Anne W. Schmidt, & Aileen McHarg. (2001). Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain. European Journal of Pharmacology. 425(3). 203–210. 38 indexed citations

Rollema, Hans, Yi Lu, Anne W. Schmidt, Jeffrey Sprouse, & Stevin H. Zorn. (2000). 5-HT1A receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex. Biological Psychiatry. 48(3). 229–237. 165 indexed citations

Rollema, Hans, et al.. (1994). MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies.. Journal of Pharmacology and Experimental Therapeutics. 268(1). 380–387. 105 indexed citations

10.

Collins, Michael A., et al.. (1992). Indole-N-methylated β-carbolinium ions as potential brain-bioactivated neurotoxins. Brain Research. 570(1-2). 154–160. 75 indexed citations

11.

Rollema, Hans, et al.. (1992). Simultaneous Measurement of Extracellular Morphine and Serotonin in Brain Tissue and CSF by Microdialysis in Awake Rats. Journal of Neurochemistry. 58(5). 1773–1781. 31 indexed citations

12.

Kalsbeek, Andries, et al.. (1990). INSENSITIVITY OF EARLY POSTNATAL RAT-BRAIN DOPAMINERGIC SYSTEMS TO 1-METHYL-4-PHENYLPYRIDINIUM ION (MPP+). University of Groningen research database (University of Groningen / Centre for Information Technology). 7(5). 425–434. 2 indexed citations

13.

Daas, Izaak den, Pieter G. Tepper, Hans Rollema, & Alan S. Horn. (1990). Transdermal administration of the dopamine agonist N-0437 and seven ester prodrugs: comparison with oral administration in the 6-OHDA turning model. Naunyn-Schmiedeberg s Archives of Pharmacology. 342(6). 655–659. 6 indexed citations

14.

Elebring, Thomas, et al.. (1988). Occurrence and pharmacological significance of metabolic ortho-hydroxylation of 5- and 8-hydroxy-2-(di-n-propylamino)tetralin. Journal of Medicinal Chemistry. 31(6). 1080–1084. 5 indexed citations

15.

Westerink, Ben H.C., et al.. (1987). The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. Naunyn-Schmiedeberg s Archives of Pharmacology. 336(5). 502–507. 202 indexed citations

16.

Rollema, Hans, et al.. (1983). BRAIN CONCENTRATIONS OF DOPAMINE ANALOGS - PARTITION-COEFFICIENTS AND BIOLOGICAL EFFECTS. Data Archiving and Networked Services (DANS). 206–210.

17.

Feenstra, Matthijs G.P., et al.. (1983). In vivo dopamine receptor binding of a non-radioactively labelled agonist, dipropyl-5, 6-ADTN. Data Archiving and Networked Services (DANS). 203–206. 5 indexed citations

18.

Rollema, Hans, et al.. (1982). STEREOSPECIFICITY OF COMT FOR THE DOPAMINE-AGONIST DIPR-5,6-ADTN. Data Archiving and Networked Services (DANS). 4(6). 205–205. 1 indexed citations

19.

Horn, A. S., et al.. (1981). SYNTHESIS AND ACTIVITY OF A METABOLITE OF THE DOPAMINERGIC AGONIST 6,7-ADTN. University of Groningen research database (University of Groningen / Centre for Information Technology). 16(5). 469–472. 6 indexed citations

20.

Horn, A. S., et al.. (1980). PRODRUGS OF SOME DOPAMINERGIC 2-AMINOTETRALINS - A REVIEW OF THEIR SYNTHESES AND NEUROCHEMICAL PROFILES. University of Groningen research database (University of Groningen / Centre for Information Technology). 15(4). 387–392. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact